SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-014475
Filing Date
2024-04-12
Accepted
2024-04-12 17:00:57
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3042059
2 ex23-1.htm EX-23.1 3944
3 ex31-1.htm EX-31.1 20861
4 ex31-2.htm EX-31.2 20847
5 ex32-1.htm EX-32.1 6675
6 ex32-2.htm EX-32.2 6635
  Complete submission text file 0001493152-24-014475.txt   11170280

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE otlc-20231231.xsd EX-101.SCH 74279
8 XBRL CALCULATION FILE otlc-20231231_cal.xml EX-101.CAL 59956
9 XBRL DEFINITION FILE otlc-20231231_def.xml EX-101.DEF 378710
10 XBRL LABEL FILE otlc-20231231_lab.xml EX-101.LAB 518263
11 XBRL PRESENTATION FILE otlc-20231231_pre.xml EX-101.PRE 458111
86 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1693515
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 24842207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)